GE Healthcare

382 articles with GE Healthcare

• Sound Technologies and GE HealthCare Announce Collaboration to Bring Vscan Air Handheld Ultrasound to Veterinary Practices Across the United States

  1/26/2023

  GE HealthCare and Sound Technologies, the global veterinary imaging leader, announced an agreement to distribute the Vscan Air™, a cutting-edge, wireless pocket-sized ultrasound that provides crystal clear image quality, whole-patient scanning capabilities, and intuitive software – to veterinary practices in the United States.

• GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023

  1/17/2023

  GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its fourth quarter and full year 2022 financial results before the market opens on Monday, January 30, 2023.

• GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

  1/10/2023

  GE HealthCare, a leader in precision care innovation, announced preliminary unaudited revenue results for the fourth quarter and full year 2022.

• GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance

  1/9/2023

  GE HealthCare announced it has entered into an agreement to acquire IMACTIS, an innovator in the rapidly growing field of computed tomography interventional guidance across an array of care areas.

• GE HealthCare Names Health Tech Pioneer Taha Kass-Hout First Chief Technology Officer

  1/5/2023

  GE HealthCare announced that Taha Kass-Hout MD, MS has been named Chief Technology Officer to lead the company’s new science and technology organization.

• GE HealthCare Completes Spin-Off and Begins Trading on Nasdaq

  1/4/2023

  GE HealthCare announced that its previously announced spin-off from GE is complete and GE HealthCare will begin trading as an independent company on the Nasdaq exchange under the ticker symbol “GEHC”.

• GE Healthcare’s AIR Recon DL Technology Recognized by Popular Science Magazine in the ‘Best of What’s New’ Awards

  11/30/2022

  GE Healthcare announced that it was recognized in the annual ‘Best of What’s New’ awards by Popular Science Magazine.

• MediView and GE Healthcare to Bring Augmented Reality Solutions to Medical Imaging for the Interventional Space

  11/28/2022

  GE Healthcare and MediView XR, Inc. announced their collaboration to integrate medical imaging into mixed reality solutions through the development of the OmnifyXR™ Interventional Suite System.1 MediView’s current technology platform leverages spatial computing and mixed reality, united with medical imaging in combining augmented reality visualization, seamless remote collaboration and evidence-based clinical insights.

• GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

  11/28/2022

  GE Healthcare will offer its own brand CT Motion injector, an innovative, multi-dose, syringeless technology developed and manufactured by ulrich medical, to a growing injector market in the U.S.

• GE Healthcare Introduces SIGNA Experience: A New Platform of Transformative Technologies that Leverage the Power of AI and Deep-Learning in MRI Scanning

  11/27/2022

  GE Healthcare announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey.

• GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

  11/27/2022

  Ahead of its planned spinoff from GE the first week of January 2023, GE Healthcare reveals over 40 solutions that aim to improve patient outcomes and increase healthcare efficiency at the Radiological Society of North America’s 2022 Annual Meeting.

• GE Healthcare Imaging Solutions Increase Workflow Efficiency and Optimize Radiologists’ Time to Help Reduce Burnout

  11/22/2022

  As radiology departments face challenges in a new era of healthcare, GE Healthcare imaging solutions are designed to support clinicians in meeting competing demands for their time and enable greater focus on patient care.

• GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity

  11/17/2022

  GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients site in Lindesnes, Norway.

• GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy

  10/21/2022

  GE Healthcare and Accuray Incorporated announced that they have signed a global commercial collaboration agreement designed to provide solutions that make it possible for more healthcare teams around the world to tailor patients' care at every stage of their treatment journey.

• GE Healthcare Tops List with Highest Number of AI-Enabled Device Authorizations, More Than Any Other Medical Technology Company

  10/20/2022

  On a recently updated FDA list of artificial intelligence (AI) enabled medical devices, GE Healthcare had the highest number of authorizations, with 42 listed 510(k) clearances to date, in the United States.

• GE Healthcare and AMC Health to Partner in Remote Patient Monitoring to Provide Patients with Chronic and Post-Acute Care in the Home

  10/19/2022

  GE Healthcare and AMC Health today announced a collaboration that allows clinicians to offer Remote Patient Monitoring (RPM) as a virtual care solution that extends patient care outside the hospital to the home environment.

• GE Healthcare Announces Collaboration to Advance Digital Transformation of Pathology

  10/18/2022

  GE Healthcare and Tribun Health have entered a collaboration with the intent to provide digital pathology departmental solutions that give healthcare providers a more holistic view of patient records.

• GE Healthcare Introduces Omni Legend: A First-of-its-Kind All-Digital PET/CT System to Drive Efficiency, Enhance Diagnostics, and Deliver on Precision Medicine

  10/16/2022

  At the European Association of Nuclear Medicine Annual Meeting, GE Healthcare proudly introduces Omni Legendi, the first system on its all-new, all-digital PET/CT platform.

• 

  FDA Review: Amylyx, Sarepta, Sanofi-Regeneron and More

  9/30/2022

  The FDA had a busy week, approving drugs, greenlighting clinical trials and other regulatory activities for Immuneering, Amylyx, Sarepta, Sanofi, and Regeneron and more. 

• GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

  9/13/2022

  GE Healthcare and Lantheus Phase III Clinical Trial Finds [ 18 F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease.